AMY HOLLAND: Open Payments
NPI 1891912465 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,852 in 32 payments from 8 companies in 2025. Trend: 2023 $528 · 2024 $10,893 · 2025 $3,852
Speaker / faculty: $2,444Food & beverage: $747Travel & lodging: $661
| Company | Payments | Amount |
|---|---|---|
| Noven Therapeutics, LLC | 20 | $2,691 |
| Neuronetics, Inc. | 3 | $946 |
| Otsuka America Pharmaceutical, Inc. | 3 | $83 |
| ABBVIE INC. | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Neos Therapeutics, LP | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
Products named: Xelstrym, NEUROSTAR TMS THERAPY SYSTEM, REXULTI, VRAYLAR, Auvelity, FANAPT, EXXUA, Relexxii.
Industry payments across GA — which companies pay providers there.
